Aspergillosis case-fatality rate: systematic review of the literature.

By Swu-Jane Lin, J. Schranz, S. Teutsch. Clinical Infectious Diseases, 2001

1,436 citations recorded by the source corpus.

Subfields: Epidemiology, Infectious Diseases

View Paper: https://www.semanticscholar.org/paper/f3a6bc99bce1ab351159573743d3b5b20df89953

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Epidemiology

1. M. Pfaller
2. D. Diekema
3. D. Kontoyiannis
4. T. Walsh
5. J. Perfect
6. J. Guinea

In Infectious Diseases

1. M. Pfaller
2. D. Diekema
3. D. Kontoyiannis
4. Henry F. Chambers
5. J. Fishman
6. J. Perfect
7. J. Guinea

Citations in the corpus

• Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America. (2008, neutral): “astating complication of invasive aspergillosis [2, 180, 181].”
• Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem (2007, neutral): “Although there continues to be concern over a perceived increase in both incidence and mortality of IA (43, 44, 51, 85, 132, 149, 154, 194), the overall incidence was almost 10fold lower than that of IC for the years 1996 through 2003 (Table 4).”
• Practice guidelines for the diagnosis and management of skin and soft-tissue infections. (2005, background): “Mortality remains high for all of these infections [188, 190].”
• Voriconazole treatment for less-common, emerging, or refractory fungal infections. (2003, background): “28 for cerebral aspergillosis) exceeds the recently published crude case fatality rates for invasive aspergillosis: 58%–62% of patients overall and 88% for patients with cerebral or disseminated aspergillosis [30, 32].”
• Efficacy and safety of caspofungin for treatment of invasive aspergillosis in patients refractory to or intolerant of conventional antifungal therapy. (2004, background): “The overall mortality rate for IA remains dramatically high, approaching 90% in populations of the most profoundly immunocompromised patients [8, 9].”
• Prevalence of culturable airborne spores of selected allergenic and pathogenic fungi in outdoor air (2008, background): “study while both Picco and Rodolfi (2000) and Awad (2005) isolated only two colonies each of S.”
• Epidemiology of Invasive Mycoses in North America (2010, background): “between 1995 and 2000 placed the attributable mortality rate at approximately 58% (Lin et al. 2001).”
• Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America. (2016, background): “CNS aspergillosis is a devastating complication with a poor prognosis in the vast majority of affected patients [427].”
• Pathogenesis of Aspergillus fumigatus in Invasive Aspergillosis (2009, background): “Mortality rates range from 40% to 90% in high-risk populations and are dependent on factors such as host immune status, the site of infection, and the treatment regimen applied (114).”